Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
viral vectors
Pharma
Patient dies after receiving Sarepta's DMD gene therapy Elevidys
The incident brings attention to the safety of AAV-based gene therapies and could spark renewed concerns over the benefit-risk profile of Elevidys.
Angus Liu
Mar 18, 2025 10:34am
Novartis debuts €40M viral vector plant in Slovenia
Feb 10, 2025 10:57am
Thermo Fisher will lay off 300 in Massachusetts as cuts continue
Feb 3, 2025 11:21am
Merck's GLP-1 play; Astellas' AAV deal—Fierce Pharma Asia
Dec 20, 2024 8:51am
Thermo Fisher to cut 160 jobs amid viral vector overhaul
Nov 11, 2024 2:48pm
UniQure sells gene therapy manufacturing facility to Genezen
Jul 1, 2024 10:46am
